Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1978 1
1980 1
1983 7
1984 1
1985 2
1987 1
1989 1
1991 2
1996 1
2001 1
2002 1
2004 5
2005 5
2006 3
2007 1
2008 1
2009 2
2010 2
2011 2
2012 5
2013 6
2014 1
2015 5
2016 5
2017 8
2018 7
2019 13
2020 20
2021 18
2022 8
2023 5
2024 3
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

132 results

Results by year

Filters applied: . Clear all
Page 1
Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Transgenic Rabbits, and Patients.
Crotti L, Neves R, Dagradi F, Musu G, Giannetti F, Bos JM, Barbieri M, Cerea P, Giovenzana FLF, Torchio M, Mura M, Gnecchi M, Conte G, Auricchio A, Sala L, Odening KE, Ackerman MJ, Schwartz PJ. Crotti L, et al. Among authors: gnecchi m. Circulation. 2024 Aug 13;150(7):531-543. doi: 10.1161/CIRCULATIONAHA.124.068959. Epub 2024 Jun 28. Circulation. 2024. PMID: 38939955
microRNA and Cardiac Regeneration.
Gnecchi M, Pisano F, Bariani R. Gnecchi M, et al. Adv Exp Med Biol. 2015;887:119-41. doi: 10.1007/978-3-319-22380-3_7. Adv Exp Med Biol. 2015. PMID: 26662989
Enhancing stem cell therapy through genetic modification.
Dzau VJ, Gnecchi M, Pachori AS. Dzau VJ, et al. Among authors: gnecchi m. J Am Coll Cardiol. 2005 Oct 4;46(7):1351-3. doi: 10.1016/j.jacc.2005.07.023. J Am Coll Cardiol. 2005. PMID: 16198854 Free article. No abstract available.
Mesenchymal stem cell therapy for heart disease.
Gnecchi M, Danieli P, Cervio E. Gnecchi M, et al. Vascul Pharmacol. 2012 Aug 19;57(1):48-55. doi: 10.1016/j.vph.2012.04.002. Epub 2012 Apr 12. Vascul Pharmacol. 2012. PMID: 22521741 Review.
Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart).
Wilkinson C, Bhatty A, Batra G, Aktaa S, Smith AB, Dwight J, Ruciński M, Chappell S, Alfredsson J, Erlinge D, Ferreira J, Guðmundsdóttir IJ, Hrafnkelsdóttir ÞJ, Ingimarsdóttir IJ, Irs A, Jánosi A, Járai Z, Oliveira-Santos M, Popescu BA, Vasko P, Vinereanu D, Yap J, Bugiardini R, Cenko E, Nadarajah R, Sydes MR, James S, Maggioni AP, Wallentin L, Casadei B, Gale CP; Global Cardiovascular Outcomes Consortium and in collaboration with ACNAP, ACVC, EACVI, EAPC, EAPCI, EHRA, ESC Committee for Young CV Professionals, ESC Registry Committee, HFA, ESC Patient Forum and these Working Groups: aorta and peripheral vascular diseases, atherosclerosis and vascular biology, cardiac cellular electrophysiology, cardiovascular pharmacotherapy, cardiovascular regenerative and restorative medicine, cardiovascular surgery, cellular biology of the heart, e-cardiology, myocardial function, pulmonary circulation and right ventricular function and thrombosis. Wilkinson C, et al. Eur Heart J. 2025 Jan 7;46(2):190-214. doi: 10.1093/eurheartj/ehae724. Eur Heart J. 2025. PMID: 39545867 Free PMC article.
132 results